State Street Corporation 13D and 13G filings for Travere Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-18 11:59 am Sale |
2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX |
STATE STREET CORP STT |
2,736,696 3.600% |
-2,615,649 (-48.87%) |
Filing |
| 2024-01-25 09:24 am Purchase |
2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
STATE STREET CORP STT |
5,352,345 7.120% |
1,128,321 (+26.71%) |
Filing |
| 2023-02-06 2:55 pm Purchase |
2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
STATE STREET CORP STT |
4,224,024 6.580% |
4,224,024 (New Position) |
Filing |